AI주식인사이트AI Stock Insight
C

더블유에스아이

299170KOSDAQ

53.0 / 100

Reference Date: 2026-10-23

Financial Score23.5 / 40
News Sentiment12.5 / 25
Momentum7.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Rose 7.7% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Double WSI is expanding its business beyond spine and joint medical device distribution by developing surgical assist robots and acquiring pharmaceutical companies. The company is creating vertical and horizontal synergies through a three-pronged business model (distribution-pharmaceuticals-medical robots), having acquired a pharmaceutical firm, Introvapharma, and a clinical trial analysis company, IBP Lab, to grow into a comprehensive healthcare enterprise.

Number of Employees

29people

Average Salary

47.7M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 15.004.0Point
PBR
0.81Industry Average 1.205.5Point

Lower than industry avg (good)

ROE
-6.45Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
25.79Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20256.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲29.4% (2-year basis)

Operating Profit Growth Rate
2.0 / 3

Avg ▲8.4% (2-year basis)

ROE Trend
1.0 / 4

Avg ROE 1.2% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (4%, downtrend)

Current 1,222Won52-week high 4,18052-week low 1,081
1-month return5.0Point

1m +7.67% (rising)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0
  • Neutral주주총회소집결의 (임시주주총회)2026-10-01
  • Neutral주주명부폐쇄기간또는기준일설정2026-10-01